Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
7
×
Tags
clinical trials
7
×
deals
7
×
life sciences
national blog main
national top stories
novartis
7
×
boston blog main
biotech
boston top stories
fda
new york blog main
new york top stories
gene therapy
national
san francisco blog main
san francisco top stories
alnylam pharmaceuticals
boulder/denver blog main
boulder/denver top stories
cancer
crispr
detroit blog main
detroit top stories
indiana blog main
indiana top stories
johnson & johnson
medicaid
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
sanofi
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
zolgensma
What
bio
deal
roundup
drug
gene
help
medicines
new
therapeutics
therapy
years
access
acquire
acquisitions
advanced
age
agreed
alzheimer’s
analytics
announced
approval
bigger
biggest
billion
biofourmis
biogen’s
biopharmaceutical
brings
capacity
car
cash
cell
ceo
cholesterol
collabs
come
companies
company
compound
congress
Language
unset
Current search:
deals
×
photo
×
novartis
×
" clinical trials "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel